The implications of the Supreme Court's decision on abortion for patients.

Published Date: 26 Apr 2023

Many women may be wondering what this means for them in light of the Supreme Court's decision on Friday regarding a crucial medication used in medical abortions.

Read Full News

Latest News

In Maternal Health Deserts, Pharmacists Are Bridging Gaps

To address high rates of maternal and infant mortality and morbidity, pharmacists in Mississippi are stepping in to provide care and connect women with obstetric care.

Antidepressants in Pregnancy: A Nuanced Story

Continuing selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with impaired neonatal adaptation but not with severe complications.

More Women With Gynecologic Issues Mistrust Medicine

Though medical mistrust may arise from systemic failures, clinicians can ensure patients feel heard and receive the care they need.

Donor Eggs Do Not Fully Negate Aging’s Effects on Fertility

New research challenges the assumption that donor oocytes can reset the reproductive clock.

Safe Pregnancies With RMDs Rise, but Challenges Remain

Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need to address male fertility and emotional care.

Miscarriage Care Model Helps Identify Modifiable Risk Sooner

A UK model finds a surprising top modifiable risk factor; patient and staff satisfaction with the model of care is high.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

To address high rates of maternal and infant mortality and morbidity, pharmacists in Mississippi are stepping in to provide care and connect women with obstetric care.

Continuing selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with impaired neonatal adaptation but not with severe complications.

Though medical mistrust may arise from systemic failures, clinicians can ensure patients feel heard and receive the care they need.

New research challenges the assumption that donor oocytes can reset the reproductive clock.

Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need to address male fertility and emotional care.

A UK model finds a surprising top modifiable risk factor; patient and staff satisfaction with the model of care is high.

News All Time

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

What Vitamin K Shot Refusals Are Really Telling Us

We can't fact-check our way out of a trust crisis

Maternal RSV Vaccine Linked to Lower Risk of Infant Hospitalization

"This is real protection, and it really applies to all comers," researcher says

Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo

Experts discuss Prosigna-guided treatment decisions in high-risk early disease

Optimizing Perioperative Therapy in Triple-Negative Breast Cancer

The treatment landscape for these patients is evolving

Tailoring Treatment for Triple-Negative Breast Cancer in Older Patients

"Most of the time we undertreat," says expert

ACOG Makes Vaccine Recommendations for the First Time

A look at how the recommendations differ from the CDC

They Told Families to 'Eat Real Food.' Now They May Cut the Produce Benefit.

To make America healthy, produce in a poor child's diet should be the last thing to go

Trump's 22 Medical Specialists; Infectious Hot Tub; Ending Postpartum Hemorrhage

Health news and commentary gathered by MedPage Today staff

Upcoming Billing Change Could Make Pregnancy Pricier

ACOG says the change is crucial to accurately reflect the care ob/gyns currently provide

Drinking in Pregnancy on the Rise, CDC Data Show

Expert urges public health campaigns to share the dangers of alcohol use in pregnancy

Mitch McConnell Hospitalized; Outbreak Deaths Reach 181; iPhones and Birth Rates

Health news and commentary gathered by MedPage Today staff

U.S. Infant Mortality Rate Falls to All-Time Low, but Trails Other Wealthy Nations

Infant deaths dropped to about 19,350 last year

Studies Raise New Questions in HR-Positive, HER2-Negative Breast Cancer

Experts discuss oral SERDs, novel targeted combinations, and sequencing

FDA Alerts on Shortage of Breast Biopsy Needles

Disruptions likely to persist through 2027, agency says

Why Some Medically Safe Births Still Feel Traumatic

Modern birth narratives may prepare women for control rather than the unpredictability of labor

Recommended News For You

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.

Study shows virtual reality headsets may help ease cancer pain

Recommended Articles For You

Clinical Methods in Hematology and Quality Improvement 

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments 

Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes 

Intratumoral Drug Distribution as a Determinant of Therapeutic Success 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The discovery of drug combinations may increase the life expectancy of children with brain cancer.

2.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

3.

High levels of traumatic stress found in caregivers of adult cancer patients

4.

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

5.

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

1.

Uncovering the Mysteries of Breast Cancer: The Journey to a Cure

2.

Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights

3.

Progressive Updates in Oncology for Healthcare Excellence

4.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

5.

Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

2.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

3.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

4.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot